| abstract |
The present invention relates to the use of a Eucalyptus extract in the preparation of a medicament or a food supplement for the treatment and/or prevention of diseases or pathologies arising from a disorder of neuromediator reuptake. The present invention relates also to an enriched Eucalyptus extract, characterised in that it comprises at least one compound of formula (I) or any one of the diastereoisomeric forms thereof: in which R1, together with the carbon atom to which it is bonded, forms a C=CH2 group or a group or and R2 represents an isobutyl, α-isobutyl or β -isobutyl group, and to a process for the preparation thereof. |